Get a Quote

Alogliptin Benzoate API | CAS# 850649-62-6
CAS NO.: 850649-62-6
Chemical Formula: C18-H21-N5-O2.C7-H6-O2
Molecular Weight: 461.5193
DMF&GMP status: Please contact us for details
Description:
Alogliptin Benzoate is an antidiabetic agent; dipeptidyl peptidase-4 (DPP-4) inhibitor. Alogliptin Benzoate is used as monotherapy as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Alogliptin Benzoate Used in combination with pioglitazone (given separately or as the fixed combination) as initial therapy as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus1 3 5 when treatment with both alogliptin and pioglitazone is appropriate.3

Alogliptin Benzoate Used in combination with metformin (given separately or as the fixed combination) as initialtherapy as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus1 2 when treatment with both alogliptin and metformin is appropriate.2

Alogliptin Benzoate Used in combination with other oral antidiabetic agents (e.g., metformin, a sulfonylurea, a thiazolidinedione [peroxisome proliferator-activated receptor-γ agonist]) or insulin as an adjunct to diet and exercise in patients with type 2 diabetes mellitus who have not achieved adequate glycemic control.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ALOGLIPTIN BENZOATETABLET; ORALEQ 12.5MG BASE NESINATAKEDA PHARMS USA
ALOGLIPTIN BENZOATE TABLET; ORAL EQ 25MG BASE NESINA TAKEDA PHARMS USA
ALOGLIPTIN BENZOATE TABLET; ORAL EQ 6.25MG BASE NESINA TAKEDA PHARMS USA
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET; ORAL EQ 12.5MG BASE; 1GM KAZANO TAKEDA PHARMS USA
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE TABLET; ORAL EQ 12.5MG BASE; 500MG KAZANO TAKEDA PHARMS USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE TABLET; ORAL EQ 12.5MG BASE; EQ 15MG BASE OSENI TAKEDA PHARMS USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE TABLET; ORAL EQ 12.5MG BASE; EQ 30MG BASE OSENI TAKEDA PHARMS USA
TABLET; ORAL EQ 12.5MG BASE; EQ 45MG BASE OSENI TAKEDA PHARMS USA
TABLET; ORAL EQ 25MG BASE; EQ 15MG BASE OSENI TAKEDA PHARMS USA
TABLET; ORAL EQ 25MG BASE; EQ 30MG BASE OSENI TAKEDA PHARMS USA
TABLET; ORAL EQ 25MG B OSENI TAKEDA PHARMS USA
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration